P. G. Pitsakis

1.3k total citations
24 papers, 1.1k citations indexed

About

P. G. Pitsakis is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, P. G. Pitsakis has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in P. G. Pitsakis's work include Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). P. G. Pitsakis is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). P. G. Pitsakis collaborates with scholars based in United States. P. G. Pitsakis's co-authors include Matthew E. Levison, Donald Kaye, Lawrence L. Livornese, Caroline C. Johnson, Gail L. Woods, Barbara Romanowski, Christine Cole Johnson, Elías Abrutyn, Mark J. Ingerman and Jerome A. Boscia and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

P. G. Pitsakis

24 papers receiving 981 citations

Peers

P. G. Pitsakis

EPIDE

PHARM

Oksana M. Korzeniowski United States

T.G. Winstanley United Kingdom

L. P. Garrod United Kingdom

D. Daneau Belgium

Óscar Cuevas Spain

Patricia A. Hogan United States

B. Pangon France

Asbjørn Digranes Norway

Kazue Ueno Japan

Silvana Noviello Italy

Oksana M. Korzeniowski United States

P. G. Pitsakis

611 ×0.9

279 ×0.6

707 ×2.3

EPIDE

167 ×0.7

246 ×1.1

PHARM

Citations per year, relative to P. G. Pitsakis P. G. Pitsakis (= 1×) peers Oksana M. Korzeniowski

Countries citing papers authored by P. G. Pitsakis

Since Specialization

Citations

This map shows the geographic impact of P. G. Pitsakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. G. Pitsakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. G. Pitsakis more than expected).

Fields of papers citing papers by P. G. Pitsakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. G. Pitsakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. G. Pitsakis. The network helps show where P. G. Pitsakis may publish in the future.

Co-authorship network of co-authors of P. G. Pitsakis

This figure shows the co-authorship network connecting the top 25 collaborators of P. G. Pitsakis. A scholar is included among the top collaborators of P. G. Pitsakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. G. Pitsakis. P. G. Pitsakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petrovas, Constantinos, Yvonne M. Mueller, Guibin Yang, et al.. (2007). Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. APOPTOSIS. 12(12). 2175–2186. 5 indexed citations

Levison, Matthew E., et al.. (2002). Regional Occurrence of Plasmid‐Mediated SHV‐7, an Extended‐Spectrum β‐Lactamase, inEnterobacter cloacaein Philadelphia Teaching Hospitals. Clinical Infectious Diseases. 35(12). 1551–1554. 22 indexed citations

Abrutyn, Elías, Jesse A. Berlin, Jana Mossey, et al.. (1996). Does Treatment of Asymptomatic Bacteriuria in Older Ambulatory Women Reduce Subsequent Symptoms of Urinary Tract Infection?. Journal of the American Geriatrics Society. 44(3). 293–295. 35 indexed citations

Johnson, Christine Cole, et al.. (1995). Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula. Journal of Antimicrobial Chemotherapy. 35(6). 765–773. 28 indexed citations

Johnson, Caroline C., et al.. (1995). In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and Enterococci. Diagnostic Microbiology and Infectious Disease. 21(3). 169–173. 41 indexed citations

Levison, Matthew E., et al.. (1993). The bactericidal activity of magainins against Pseudomonas aeruginosa and Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 32(4). 577–585. 10 indexed citations

Woods, Gail L., et al.. (1993). Evaluation of MicroScan rapid panels for detection of high-level aminoglycoside resistance in enterococci. Journal of Clinical Microbiology. 31(10). 2786–2787. 9 indexed citations

Whitman, Marc, P. G. Pitsakis, Lawrence L. Livornese, et al.. (1993). Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 37(10). 2069–2073. 39 indexed citations

Livornese, Lawrence L., Barbara Romanowski, P. G. Pitsakis, et al.. (1992). Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers. Annals of Internal Medicine. 117(2). 112–116. 413 indexed citations

10.

Abrutyn, Elías, Jana Mossey, Matthew E. Levison, et al.. (1992). Risk factors for asymptomatic bacteriuria in elderly ambulatory women. 2(2). 99–103. 2 indexed citations

11.

Abrutyn, Elías, Jana Mossey, Matthew E. Levison, et al.. (1991). Epidemiology of Asymptomatic Bacteriuria in Elderly Women. Journal of the American Geriatrics Society. 39(4). 388–393. 53 indexed citations

12.

Pitsakis, P. G., et al.. (1990). Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 34(6). 1143–1145. 12 indexed citations

13.

Pitsakis, P. G., et al.. (1989). Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 33(5). 608–611. 44 indexed citations

14.

Levison, Matthew E. & P. G. Pitsakis. (1987). Susceptibility to Experimental Candida albicans Urinary Tract Infection in the Rat. The Journal of Infectious Diseases. 155(5). 841–846. 35 indexed citations

15.

Ingerman, Mark J., et al.. (1987). -Lactamase Production in Experimental Endocarditis Due to Aminoglycoside-Resistant Streptococcus faecalis. The Journal of Infectious Diseases. 155(6). 1226–1232. 58 indexed citations

16.

Ingerman, Mark J., P. G. Pitsakis, Alexander F. Rosenberg, & Matthew E. Levison. (1986). The Importance of Pharmacodynamics in Determining the Dosing Interval in Therapy for Experimental Pseudomonas Endocarditis in the Rat. The Journal of Infectious Diseases. 153(4). 707–714. 49 indexed citations

17.

Levison, Matthew E. & P. G. Pitsakis. (1984). Effect of Insulin Treatment on the Susceptibility of the Diabetic Rat to Escherichia coli-Induced Pyelonephritis. The Journal of Infectious Diseases. 150(4). 554–560. 13 indexed citations

18.

Levison, Sandra P., P. G. Pitsakis, & Matthew E. Levison. (1982). Free water reabsorption during saline diuresis in experimental enterococcal pyelonephritis in rats.. PubMed. 99(4). 474–80. 2 indexed citations

19.

Pitsakis, P. G., et al.. (1981). Experimental Candida albicans, Staphylococcus aureus, and Streptococcus faecalis pyelonephritis in diabetic rats. Infection and Immunity. 34(3). 773–779. 29 indexed citations

20.

Levison, Sandra P., Matthew E. Levison, & P. G. Pitsakis. (1978). Papillary plasma flow in experimental pyelonephritis in rats: effect of antibiotic therapy and indomethacin.. PubMed. 92(4). 570–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact